Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 392

1.

Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation.

Böttcher J, Hansch A, Pfeil A, Schmidt P, Malich A, Schneeweiss A, Maurer MH, Streitparth F, Teichgräber UK, Renz DM.

Eur J Radiol. 2013 Nov;82(11):1860-9. doi: 10.1016/j.ejrad.2013.06.013. Epub 2013 Aug 7.

PMID:
23932636
2.

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.

Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.

Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b.

PMID:
20098330
3.

Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.

Donati OF, Fischer MA, Chuck N, Hunziker R, Weishaupt D, Reiner CS.

Eur J Radiol. 2013 May;82(5):822-8. doi: 10.1016/j.ejrad.2012.12.005. Epub 2012 Dec 31.

PMID:
23287713
4.

Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients: a multicenter, open-label, phase III study.

Zeng MS, Ye HY, Guo L, Peng WJ, Lu JP, Teng GJ, Huan Y, Li P, Xu JR, Liang CH, Breuer J.

Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):607-16.

PMID:
24322746
5.

Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.

Haimerl M, Wächtler M, Platzek I, Müller-Wille R, Niessen C, Hoffstetter P, Schreyer AG, Stroszczynski C, Wiggermann P.

BMC Med Imaging. 2013 Dec 1;13:41. doi: 10.1186/1471-2342-13-41.

6.

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.

Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, Fusté LC, Heinz-Peer G, Judmaier W, Laniado M, Manfredi RM, Mathieu DG, Müller D, Mortelè K, Reimer P, Reiser MF, Robinson PJ, Shamsi K, Strotzer M, Taupitz M, Tombach B, Valeri G, van Beers BE, Vogl TJ; European EOB-study group.

Eur Radiol. 2008 Mar;18(3):457-67. Epub 2007 Dec 6.

PMID:
18058107
7.

Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.

Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D.

J Nucl Med. 2010 May;51(5):692-9. doi: 10.2967/jnumed.109.068510. Epub 2010 Apr 15.

8.

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.

Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT Jr, Lu D, Paulson EK, Schwartz LH, Siegelman ES, Small WC, Weber TM, Welber A, Shamsi K.

Radiology. 2005 Oct;237(1):89-98. Epub 2005 Aug 26.

PMID:
16126918
9.

Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO.

Invest Radiol. 2008 Jul;43(7):504-11. doi: 10.1097/RLI.0b013e3181705cd1.

PMID:
18580333
10.

Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.

Benndorf M, Schelhorn J, Dietzel M, Kaiser WA, Baltzer PA.

Eur J Radiol. 2012 Aug;81(8):e849-53. doi: 10.1016/j.ejrad.2012.03.027. Epub 2012 May 8.

PMID:
22575171
11.

Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.

Haradome H, Grazioli L, Tinti R, Morone M, Motosugi U, Sano K, Ichikawa T, Kwee TC, Colagrande S.

J Magn Reson Imaging. 2011 Jul;34(1):69-78. doi: 10.1002/jmri.22588. Epub 2011 May 19.

PMID:
21598343
12.

Application of classification trees for the qualitative differentiation of focal liver lesions suspicious for metastasis in gadolinium-EOB-DTPA-enhanced liver MR imaging.

Schelhorn J, Benndorf M, Dietzel M, Burmeister HP, Kaiser WA, Baltzer PA.

Rofo. 2012 Sep;184(9):788-94. Epub 2012 May 22.

PMID:
22618476
13.

Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.

Péporté AR, Sommer WH, Nikolaou K, Reiser MF, Zech CJ.

Eur J Radiol. 2013 Mar;82(3):e101-6. doi: 10.1016/j.ejrad.2012.10.010. Epub 2012 Nov 16.

PMID:
23159401
14.

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.

Lee KH, Lee JM, Park JH, Kim JH, Park HS, Yu MH, Yoon JH, Han JK, Choi BI.

Korean J Radiol. 2013 Nov-Dec;14(6):894-904. doi: 10.3348/kjr.2013.14.6.894. Epub 2013 Nov 5.

15.

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.

Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T.

J Gastroenterol. 2012 Sep;47(9):1036-47. doi: 10.1007/s00535-012-0571-6. Epub 2012 Apr 17.

PMID:
22526270
16.

Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.

Haimerl M, Wächtler M, Zeman F, Verloh N, Platzek I, Schreyer AG, Stroszczynski C, Wiggermann P.

PLoS One. 2014 Jun 20;9(6):e100315. doi: 10.1371/journal.pone.0100315. eCollection 2014.

17.

Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.

Akai H, Kiryu S, Matsuda I, Satou J, Takao H, Tajima T, Watanabe Y, Imamura H, Kokudo N, Akahane M, Ohtomo K.

Eur J Radiol. 2011 Nov;80(2):310-5. doi: 10.1016/j.ejrad.2010.07.026. Epub 2010 Aug 21.

PMID:
20732773
18.

Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging.

Chung YE, Kim MJ, Kim YE, Park MS, Choi JY, Kim KW.

PLoS One. 2013 Jun 11;8(6):e66141. doi: 10.1371/journal.pone.0066141. Print 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/a03efa25-49f8-4616-a256-074a3d60ceaf.

19.

Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT.

Baek CK, Choi JY, Kim KA, Park MS, Lim JS, Chung YE, Kim MJ, Kim KW.

Clin Radiol. 2012 Feb;67(2):148-56. doi: 10.1016/j.crad.2011.08.011. Epub 2011 Sep 13.

PMID:
21920517
20.

Supplemental Content

Support Center